FDA considers first CRISPR gene editing treatment that may cure sickle cell

Re:FDA considers first CRISPR gene editing treatment that ma... by nxobject on Tuesday November 21, 2023 @07:36AM (#38362797)

IIRC, single-payer health care systems like the NHS do functionally the exact same thing, which allows them to negotiate significant discounts. I remember reading about a gene therapy for a type of leukodystropphy that was in the millions of dollars, but got negotiated down. [1]